Company: DARE
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001401914-25-000044
Chunk: 47

Company: Dare Bioscience, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 47
---
2420252024Operating lease cost$225,000 $191,000 $424,000 $391,000 Finance lease costAmortization of finance lease450,000 — 600,000 — Interest on finance lease liability54,000 — 73,000 — Total lease cost$729,000 $191,000 $1,097,000 $391,000 Maturities of the Company's finance and operating lease liabilities as of June 30, 2025 were as follows:YearOperating LeasesFinance LeaseTotal2025 (remaining)$331,000 $462,000 $793,000 2026680,000 1,658,000 2,338,000 2027130,000 — 130,000 Total lease payments1,141,000 2,120,000 3,261,000 Less: amount representing interest(104,000)(124,000)(228,000)Present value of lease liabilities$1,037,000 $1,996,000 $3,033,000 The weighted-average remaining lease terms and discount rates related to the Company's leases were as follows:As of June 30,20252024Weighted-average remaining lease term (in years)Operating leases1.922.92Finance lease1.50— Weighted-average discount rateOperating leases10.5 %10.5 %Finance lease9.5 %— %

19

Supplemental cash flow information related to the Company's leases was as follows:Three Months Ended June 30,Six Months EndedJune 30,2025202420252024Cash paid for amounts included in the measurement of lease liabilitiesFinancing cash flows from finance lease$448,000 $— $459,000 $— Operating cash flows from finance lease$54,000 $— $73,000 $— Operating cash flows from operating leases$164,000 $159,000 $329,000 $318,000 

7.    ROYALTY INTEREST FINANCING

In December 2023, the Company entered into a royalty interest financing agreement, or the Royalty Interest Agreement, with United in Endeavour, LLC, or UiE, under which UiE acquired a portion of the Company's royalty interest in XACIATO. The Company received $5.0 million